ZOSANO PHARMA CORP's ticker is ZSAN and the CUSIP is 98979H202. A total of 32 filers reported holding ZOSANO PHARMA CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $32,000 | -8.6% | 144,667 | +93.1% | 0.00% | – |
| Q4 2021 | $35,000 | +400.0% | 74,912 | +673.7% | 0.00% | – |
| Q3 2021 | $7,000 | -30.0% | 9,682 | -6.7% | 0.00% | – |
| Q2 2021 | $10,000 | -56.5% | 10,377 | -43.5% | 0.00% | – |
| Q1 2021 | $23,000 | +64.3% | 18,352 | -34.1% | 0.00% | – |
| Q4 2020 | $14,000 | -93.5% | 27,859 | -78.9% | 0.00% | – |
| Q3 2020 | $214,000 | +275.4% | 131,973 | +99.4% | 0.00% | – |
| Q2 2020 | $57,000 | +1.8% | 66,172 | -33.8% | 0.00% | – |
| Q1 2020 | $56,000 | -46.7% | 99,932 | +45.8% | 0.00% | – |
| Q4 2019 | $105,000 | +90.9% | 68,557 | +93.1% | 0.00% | – |
| Q3 2019 | $55,000 | -68.9% | 35,500 | -34.4% | 0.00% | – |
| Q2 2019 | $177,000 | +35.1% | 54,094 | +96.7% | 0.00% | – |
| Q1 2019 | $131,000 | +718.8% | 27,500 | +266.7% | 0.00% | – |
| Q4 2018 | $16,000 | -5.9% | 7,500 | +74.8% | 0.00% | – |
| Q3 2018 | $17,000 | +1600.0% | 4,290 | +1602.4% | 0.00% | – |
| Q1 2018 | $1,000 | – | 252 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 1,172,542 | $1,900,000 | 1.90% |
| Aisling Capital Management LP | 2,718,226 | $4,404,000 | 1.41% |
| Telemetry Investments, L.L.C. | 239,830 | $389,000 | 0.84% |
| Sio Capital Management, LLC | 452,542 | $733,000 | 0.14% |
| AJ WEALTH STRATEGIES, LLC | 136,476 | $221,000 | 0.02% |
| CAAS CAPITAL MANAGEMENT LP | 453,168 | $734,000 | 0.02% |
| Highlander Capital Management, LLC | 10,000 | $16,000 | 0.01% |
| Qube Research & Technologies Ltd | 427,894 | $693,000 | 0.01% |
| Alyeska Investment Group, L.P. | 295,953 | $479,000 | 0.01% |
| WINTON GROUP Ltd | 120,182 | $195,000 | 0.01% |